Why Healthcare PE Firms Are Outsourcing Peptide Billing
Peptide therapy is growing fast across healthcare. Private equity firms that own clinics need a smart way to handle billing for these treatments.
Outsourcing peptide billing can save money and reduce errors. It also frees up your team to focus on patient care and growth.
Ben Briggs, Senior Director of Healthcare Services, McKinsey & Company: "Revenue cycle outsourcing allows private equity portfolio companies to standardize billing operations across acquisitions, reducing integration timelines and improving cash flow predictability"
The True Cost of In-House Peptide Billing
Running peptide billing in-house costs more than most people think. You need to pay for staff, training, software, and ongoing compliance updates.
A full-time billing specialist can cost $50,000 to $75,000 per year in salary alone. Add benefits, office space, and software licenses, and the total often climbs past $100,000 per person.
The average healthcare practice spends 30% more on in-house billing than outsourced billing when you factor in training, turnover, and technology costs.
Outsourced billing teams recover up to 15% more revenue on denied claims compared to in-house teams, largely because they dedicate full-time resources to denial management and payer follow-up.
Common Pricing Models for Outsourced Peptide Billing
Most outsourced billing companies use one of three pricing models. Each one works differently depending on your volume and needs.
Percentage of collections is the most common model. The billing company takes a cut of what they collect, usually between 4% and 10% of revenue.
Flat monthly fee pricing gives you a set cost each month. This works well for PE firms that want predictable expenses across their portfolio.
Per-claim pricing charges you for each claim submitted. This model is good for practices with lower peptide therapy volume.
What Drives the Cost of Outsourced Peptide Billing?
Several factors affect how much you will pay. The size of your portfolio and the number of claims are the biggest drivers.
Claim complexity also matters a lot. Peptide therapies often need special codes and documentation that require extra expertise.
The level of service you need plays a role too. Some firms want full revenue cycle management while others just need claims submission.
The total cost of outsourcing peptide billing for a mid-size PE healthcare portfolio typically ranges from $3,000 to $15,000 per month, depending on volume and service level.
How Outsourcing Saves Money for PE Portfolios
PE firms care about margins and returns. Outsourcing peptide billing can improve both in several ways.
First, you cut fixed labor costs and turn them into variable costs. This makes it easier to scale up or down as your portfolio changes.
Second, expert billing teams catch more revenue. They know the right codes and follow up on denials faster than most in-house teams.
Third, you reduce compliance risk. Peptide billing has special rules, and mistakes can lead to audits, fines, or lost revenue.
Hidden Costs to Watch Out For
Not all outsourced billing deals are the same. Some companies charge setup fees, technology fees, or early termination penalties.
Ask about costs for things like reporting, patient statements, and credentialing. These extras can add up if they are not included in your base price.
Make sure you understand what happens with denied claims. Some companies charge extra to rework and resubmit claims that get rejected.
Before signing with an outsourced billing vendor, request a full fee schedule that includes setup, reporting, credentialing, and early termination costs so you can compare true all-in pricing across providers.
How to Compare Outsourced Billing Costs Across Vendors
Start by listing everything your current billing process costs. Include salaries, benefits, software, training, and the cost of errors and rework.
Then get quotes from at least three outsourced billing companies. Make sure each quote covers the same services so you can compare apples to apples.
Look beyond just the price tag. A company that charges more but collects 15% more revenue could be the better deal.
What PE Firms Should Look for in a Billing Partner
Experience with peptide therapy billing is a must. Peptide treatments use specific CPT and HCPCS codes that not every biller knows. For additional context, the FDA guidance on contract manufacturing offers relevant guidance on this topic.
Look for a partner that understands the PE model. They should be able to handle multiple locations and report data in a way that supports your investment thesis.
Scalability is also important. Your billing partner should be able to grow with your portfolio without big jumps in cost.
The ROI of Outsourced Peptide Billing
Most PE firms see a return on their outsourcing investment within 60 to 90 days. The savings come from lower labor costs, fewer errors, and faster collections.
Clean claim rates often improve from 85% to 95% or higher with a good billing partner. That means more money in the door and less time chasing payments.
PE-backed healthcare practices that outsource billing report an average revenue increase of 10% to 20% in the first year due to fewer denials and faster reimbursement.
Steps to Get Started with Outsourced Peptide Billing
First, audit your current billing performance. Know your clean claim rate, days in accounts receivable, and denial rate before you shop for a partner.
Next, define what services you need. Decide if you want full revenue cycle management or just help with claims and coding.
Then reach out to billing companies that specialize in peptide therapy. Ask for references from other PE-backed healthcare groups.
For most PE-backed healthcare portfolios, outsourcing peptide billing converts unpredictable fixed overhead into a scalable variable cost while improving collection rates and compliance.
Frequently Asked Questions
How much does outsourced peptide billing typically cost? Most outsourced peptide billing services charge between 4% and 10% of collections or a flat monthly fee starting around $3,000. The exact cost depends on your claim volume, complexity, and the level of service you need.
Is outsourcing billing really cheaper than doing it in-house? Yes, in most cases outsourcing is 20% to 40% cheaper than in-house billing when you add up all costs. In-house billing requires salaries, benefits, training, software, and management overhead that outsourcing eliminates.
How long does it take to switch to an outsourced billing company? Most transitions take 30 to 60 days from start to finish. A good billing partner will handle the heavy lifting and make sure no claims fall through the cracks during the switch.
Will outsourcing affect our revenue cycle performance? Outsourcing usually improves revenue cycle performance right away. Expert billers have higher clean claim rates and shorter collection cycles than most in-house teams.
Can one billing partner handle our entire PE portfolio? Yes, many billing companies specialize in serving multi-location healthcare groups and PE portfolios. Look for a partner with experience scaling across multiple practices and specialties.
Take Control of Your Peptide Billing Costs Today
PeptideStaff helps healthcare PE firms outsource peptide billing with confidence. Our team knows the codes, the compliance rules, and the PE model inside and out.
Contact us today for a free cost analysis and see how much your portfolio could save. We will show you the numbers and build a plan that fits your goals.
Topics
Jennifer Walsh
Senior Healthcare Staffing Consultant
RN, BSN | 13 years placing clinical professionals in wellness practices
Registered nurse and staffing specialist who has placed over 400 clinical professionals across peptide therapy, hormone optimization, and integrative medicine clinics. Expertise in credentialing and retention strategy.
Reviewed by Jennifer Walsh, RN, April 2026